Pancreatic function in carboxyl-ester lipase knockout mice

Pancreatology

Volumn 10, Issue 4, 2010, Pages 467-476

  Vesterhus, Mette ^a,b,d   Ræder, Helge ^a,b,d   Kurpad, Amarnath J ^c   Kawamori, Dan ^c   Molven, Anders ^a,b   Kulkarni, Rohit N ^c   Kahn, C Ronald ^d   Njølstad, Pål Rasmus ^a,b,d  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOSLIN DIABETES CENTER   (United States)

Author keywords

Carboxyl ester lipase; Exocrine dysfunction; MODY

Indexed keywords

CARBOXYL ESTER LIPASE; GLUCOSE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HISTOPATHOLOGY; HOMEOSTASIS; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL;

EID: 77955606292     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000266284     Document Type: Article

References (34)

1. Sagen JV, Ræder H, Hathout E, Shehadeh N, Gudmundsson K, Bævre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Søvik O, Njøl-stad PR: Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004; 53: 2713-2718.
2. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE , Lark in B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slinger-land AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT: Switching from insulin to oral sulfonyl-ureas in patients with diabetes due to Kir6.2 mutat ions. N Engl J Med 2006; 355: 467-477.
3. Bellanne-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, Noel LH, Velho G, Timsit J: Clinical spectrum associated with hepatocyte nuclear factor-1fi mutations. Ann Intern Med 2004; 140: 510-517.
4. Sellick GS, Barker KT, Stolte-Dijkstra I, Fleischmann C, Coleman RJ, Garrett C, Gloyn AL, Edghill EL, Hattersley AT, Wellauer PK, Goodwin G, Houlston RS: Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004; 36: 1301-1305.
5. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997; 15:106-110.
6. Delepine M, Nicolino M, Barrett T, Gola-maully M, Lathrop GM, Julier C: EIF2AK3, encoding translation initiation factor 2a kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000; 25:406-409.
7. Ræder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bjørkhaug L, Sagen JV, Aksnes L, Søvik O, Lombardo D, Molven A, Njølstad PR: Mutations in the CEL VNTR cause a syndrome of diabetes and exocrine dysfunction. Nat Genet 2006; 38:54-62.
8. Poorkhalkali N, Lidmer AS, Lundberg LG, Dalrymple MA, Gibson Y, Taylor L, Temper-ley S, Stromqvist M, Helander HF: Bile salt-stimulated lipase (BSSL) distribution in rat, mouse and transgenic mouse expressing human BSSL. Histochem Cell Biol 1998; 110: 367-376.
9. Lombardo D: Bile salt-dependent lipase: its pathophysiological implications. Biochim Biophys Acta 2001; 1533: 1-28.
10. Howles PN, Carter CP, Hui DY: Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J Biol Chem 1996; 71: 7196-7202.
11. Weng W, Li L, van Bennekum AM, Potter SH, Harrison EH, Blaner WS, Breslow JL, Fisher EA: Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl-ester lipase knockout mice. Biochemistry 1999; 38:4143-4149.
12. Kirby RJ, Zheng S, Tso P, Howles PN, Hui DY: Bile salt-stimulated carboxyl-ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via ceramide hydrolysis. J Biol Chem 2002; 277: 4104-4109.
13. Jandacek RJ, Heubi JE, Tso P: A novel, noninvasive method for the measurement of intestinal fat absorption. Gastroenterology 2004; 127: 139-144.
14. Zenker M, Mayerle J, Lerch MM, Tagariello A, Zerres K, Durie PR, Beier M, Hulskamp G, Guzman C, Rehder H, Beemer FA, Hamel B, Vanlieferinghen P, Gershoni-Baruch R Vieira MW, Dumic M, Auslender R Gil-da-Silva-Lopes VL, Steinlicht S, Rauh M, Shalev SA, Thiel C, Ekici AB, Winterpacht A, Kwon YT, Varshavsky A, Reis A: Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Jo-hanson-Blizzard syndrome). Nat Genet 2005; 37: 1345-1350.
15. Kulkarni RN, Bruning JC, Winnay JN, Pos-tic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic p cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999; 96:329-339.
16. Raeymaekers L: Basic principles of quantitative PCR. Mol Biotechnol 2000; 15:115-122.
17. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR: Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter 3-cell mass. Nat Genet 2002; 31:111-115.
18. Leiter EH, Chapman HD, Coleman DL: The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransfer-ases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 1989; 124:912-922.
19. Goren HJ, Kulkarni RN, Kahn CR: Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology 2004; 145:3307-3323.
20. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, Kahn CR: Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 2003; 52:1528-1534.
21. Pi J, Bai Y, Daniel KW, Liu D, Lyght O, Edel-stein D, Brownlee M, Corkey BE, Collins S: Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic 3-cell function. Endocrinology 2009; 150: 3040-3048.
22. Ræder H, Haldorsen IS, Ersland L, Gruner R Taxt T, Søvik O, Molven A, Njølstad PR: Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 2007; 56: 444-449.
23. Lankisch PG, Schmidt I, Konig H, Lehnick D, Knollmann R, Lohr M, Liebe S: Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42:551-554.
24. Gilham D, Labonte ED, Rojas JC, Jandacek RJ, Howles PN, Hui DY: Carboxyl-ester lipase deficiency exacerbates dietary lipid absorption abnormalities and resistance to diet-induced obesity in pancreatic triglyceride lipase knockout mice. J Biol Chem 2007; 282: 24642-24649
25. Winkler KE, Harrison EH, Marsh JB, Glick JM, Ross AC: Characterization of a bile salt-dependent cholesteryl ester hydrolase activity secreted from HepG2 cells. Biochim Biophys Acta 1992; 1126:151-158.
26. Van Bennekum AM, Li L, Piantedosi R, Shamir R, Vogel S, Fisher EA, Blaner WS, Harrison EH: Carboxyl-ester lipase overex-pression in rat hepatoma cells and CEL deficiency in mice have no impact on hepatic uptake or metabolism of chylomicron-retinyl ester. Biochemistry 1999; 38: 4150-4156.
27. Lindner T, Gragnoli C, Furuta H, Cockburn BN, Petzold C, Rietzsch H, Weiss U, Schulze J, Bell GI: Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4a/MODY1 gene. J Clin Invest 1997; 100:1400-1405.
28. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA: Hepatocyte nuclear factor 4a controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34: 292-296.
29. Roep BO: Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann NY Acad Sci 2007; 1103:1-10.
30. Antonarakis SE, Beckmann JS: Mendelian disorders deserve more attention. Nat Rev Genet 2006; 7:277-282.
31. Rossmeisl M, Rim JS, Koza RA, Kozak LP: Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes 2003; 52: 1958-1966.
32. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C: Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 2005; 202:805-815.
33. Kannius-Janson M, Lidberg U, Bjursell G, Nilsson J: The tissue-specific regulation of the carboxyl-ester lipase gene in exocrine pancreas differs significantly between mouse and human. Biochem J 2000; 351: 367-376.
34. Hui DY, Howles PN: Carboxyl-ester lipase: structure-function relationship and physiological role in lipoprotein metabolism and atherosclerosis. J Lipid Res 2002; 43:2017-2030.